Improving the quality of life in patients with vestibular disorders: The role of medical treatments and physical rehabilitation

International Journal of Clinical Practice

Volumn 62, Issue 1, 2008, Pages 109-114

  Mira, E ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETAHISTINE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNARIZINE; GENTAMICIN; PLACEBO; STEROID;

AGING; AGORAPHOBIA; ANXIETY; BALANCE DISORDER; BODY POSTURE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DISABILITY; DIZZINESS; DRUG EFFICACY; DRUG MECHANISM; FALLING; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEALTH STATUS; HOME CARE; HUMAN; KINESIOTHERAPY; MENIERE DISEASE; MENTAL DISEASE; PANIC; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SELF CONCEPT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VERTIGO; VESTIBULAR DISORDER;

BETAHISTINE; HISTAMINE AGONISTS; HUMANS; QUALITY OF LIFE; VERTIGO; VESTIBULAR DISEASES;

EID: 37349035647     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01091.x     Document Type: Review

References (56)

1. Toole JF. Some neurologic syndromes. In : Barondess JA, Carpenter CC, eds. Differential Diagnosis. Philadelphia : Lea & Febiger 1994 : 701 24.
2. Hanley K, O'Dowd T, Considine N. A systematic review of vertigo in primary care. Br J Gen Pract 2001 51 : 666 71.
3. Kroenke K, Lucas CA, Rosenberg ML et al. Causes of persistent dizziness. A prospective study of 100 patients in ambulatory care. Ann Intern Med 1992 117 : 898 904.
4. Hanley K, O'Dowd T. Symptoms of vertigo in general practice: a prospective study of diagnosis. Br J Gen Pract 2002 52 : 809 12.
5. Hotson JR, Baloh RW. Acute vestibular syndrome. N Engl J Med 1998 339 : 680 5.
6. Beers MH, Berkow R. Merck Manual of Diagnosis and Therapy, 17th edn. Whitehouse Station, NJ : Merck & Co., 1999 : 665 7, 678 83.
7. Soderman AC, Bagger-Sjoback D, Bergenius J, Langius A. Factors influencing quality of life in patients with Meniere's disease, identified by a multidimensional approach. Otol Neurotol 2002 23 : 941 8.
8. Fielder H, Denholm SW, Lyons RA, Fielder CP. Measurements of health status in patients with vertigo. Clin Otolaryngol 1996 21 : 124 6.
9. Aggarwal NY, Bennett DA, Bienias JL, Mendes Leon de CF, Morris MC, Evans DA. The prevalence of dizziness and its association with functional disability in a biracial community population. J Gerontol A Biol Sci Med Sci 2000 55 : M288 92.
10. Monzani D, Casolari L, Guidetti G, Rigatelli M. Psychological distress and disability in patients with vertigo. Psychosom Res 2001 50 : 319 23.
11. Pothula VB, Chew F, Lesser TH, Sharma AK. Falls and vestibular impairment. Clin Otolaryngol Allied Sci 2004 29 : 179 82.
12. Gufoni M, Guidetti G, Nuti D et al. The relationship between cognitive impairment, anxiety-depression symptoms and balance and spatial orientation complaints in the elderly. Acta Otorhinolaryngol Ital 2005 25 (3 Suppl 79 12 21.
13. Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 1990 116 : 424 7.
14. Ware JE, Snow KK, Kosinski M et al. SF-36 Health Survey: Manual and Interpretation Guide. QualityMetrie, Lincoln, RI, 1993.
15. Shepard NT, Telain SA. Practical Management of the Balance Disordered Patient. Singular Publishing Group, San Diego, CA, 1996.
16. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol 1995 50 : M28 34.
17. Cohen HS, Kimball KT. Development of the vestibular disorders activities of daily living scale. Arch Otolaryngol Head Neck Surg 2000 126 : 881 7.
18. Albera R, Ciuffolotti R, Di Cicco M et al. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 2003 123 : 588 93.
19. Tinetti ME. Falls. In : Hazzard WR, Andres R, Bierman EL, eds. Principles of Geriatric Medicine and Gerontology, 2nd edn. New York : McGraw-Hill 1990 : 1192 9.
20. Herdman SJ, Blatt P, Schubert MC, Tusa RJ. Falls in patients with vestibular deficits. Am J Otol 2000 21 : 847 51.
21. Oghalai JS, Manolidis S, Barth JL, Stewart MG, Jenkins HA. Unrecognized benign paroxysmal vertigo in elderly patients. Otolaryngol Head Neck Surg 2000 122 : 630 4.
22. Balaban CD, Jacob RG. Background and history of the interface between anxiety and vertigo. J Anxiety Disord 2001 15 : 27 51.
23. Yardley L, Beech S, Zander L, Evans T, Weinman J. A randomized controlled trial of exercise therapy for dizziness and vertigo in primary care. Br J Gen Pract 1998a 48 : 1136 40.
24. Yardley L, Burgneay J, Nazareth I, Luxon L. Neuro-otological and psychiatric abnormalities in a community sample of people with dizziness: a blind, controlled investigation. J Neurol Neurosurg Psychiatry 1998b 65 : 679 84.
25. Yardley L. Overview of psychologic effects of chronic dizziness and balance disorders. Otolaryngol Clin North Am 2000 33 : 603 16.
26. Yardley L, Owen N, Nazareth I, Luxon L. Panic disorder with agoraphobia associated with dizziness: characteristic symptoms and psychosocial sequelae. J Nerv Ment Dis 2001 189 : 321 7.
27. Staab JP, Ruckenstein MJ. Which comes first? Psychogenic dizziness versus otogenic anxiety. Laryngoscope 2003 113 : 1714 8.
28. Jacob RG, Furman JM, Durrant JD, Turner SM. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry 1996 153 : 503 12.
29. Yardley L, Putman J. Quantitative analysis of factors contributing to handicap and distress in vertiginous patients: a questionnaire study. Clin Otolaryngol Allied Sci 1992 17 : 231 6.
30. Eagger S, Luxon LM, Davies RA, Coelho A, Ron MA. Psychiatric morbidity in patients with peripheral vestibular disorder: a clinical and neuro-otological study. J Neurol Neurosurg Psychiatry 1992 55 : 383 7.
31. Pollak L, Klein C, Rafael S et al. Anxiety in the first attack of vertigo. Otolaryngol Head Neck Surg 2003 128 : 829 34.
32. Yardley L, Redfern MS. Psychological factors influencing recovery from balance disorders. Anxiety Disord 2001 15 : 107 19.
33. Smith PF, Zheng Y, Horii A, Darlington CL. Does vestibular damage cause cognitive dysfunction in humans J Vestib Res 2005 15 : 1 9.
34. Yardley L, Dibb B, Osborne G. Factors associated with quality of life in Meniere's disease. Clin Otolaryngol Allied Sci 2003 28 : 436 41.
35. Cohen HS, Wells J, Kimball KT, Owsley C. Driving disability and dizziness. J Safety Res 2003 34 : 361 9.
36. Magliulo G, Bertin S, Ruggieri M, Gagliardi M. Benign paroxysmal positional vertigo and post-treatment quality of life. Eur Arch Otorhinolaryngol 2005 262 : 627 30.
37. Claes J, Van de Heyning PH. A review of medical treatment for Meniere's disease. Acta Otolaryngol Suppl 2000 544 : 34 9.
38. Mira E, Guidetti G, Ghilardi L, Fattori B, Malannino N, Maiolino L et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003 260 : 73 7.
39. Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol Head Neck Surg 2003 128 : 60 70.
40. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003 17 : 85 100.
41. Hecker HC, Hau CO, Herndon JW. Treatment of vertiginous patient using Cawthorne's vestibular exercises. Laryngoscope 1974 11 : 2065 72.
42. Cohen H. Vestibular rehabilitation reduces functional disability. Otolaryngol Head Neck Surg 1992 107 : 638 43.
43. Cohen HS. Disability and rehabilitation in the dizzy patient. Curr Opin Neurol 2006 19 : 49 54.
44. Cohen H. Vestibular rehabilitation improves daily life function. Am J Occup Ther 1994 48 : 919 25.
45. Yardley L, Donovan-Hall M, Smith HE, Walsh BM, Mullee M, Bronstein AM. Effectiveness of primary care-based vestibular rehabilitation for chronic dizziness. Ann Intern Med 2004 141 : 598 605.
46. Mira E. Betahistine in the treatment of vertigo. History and clinical implications of recent pharmacological researches. Acta Otorhinolaryngol Ital 2001 21 (3 Suppl 66 1 7.
47. Lacour M, Sterkers O. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action. CNS Drugs 2001 15 : 853 70.
48. Schmidt TJ, Huizing EH. The clinical drug trial in Meniere's disease with emphasis on the effect of betahistine SR. Acta Ootolaryngol (Stockh) 1992 497 : 1 189.
49. Elia JC. Double blind evaluation of a new treatment for Meniere's syndrome. JAMA 1966 196 : 187 9.
50. Bertrand RA. Long-term evaluation of the treatment of Meniere's disease with betahistine HCl. Adv Otorhinolaryngol 1982 28 : 104 10.
51. Oosterveld WJ. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study. J Laryngol Otol 1984 98 : 37 41.
52. Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Meniere's disease. Acta Otolaryngol Suppl 1991 490 : 1 10.
53. Frew IJ, Menon GN. Betahistine hydrochloride in Meniere's disease. Postgrad Med J 1976 52 : 501 3.
54. Wilmot TJ, Menon GN. Betahistine in Meniere's disease. J Laryngol Otol 1976 90 : 833 40.
55. Colletti V. Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol Suppl 2000 544 : 27 33.
56. Elbaz P. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study. Acta Otolaryngol Suppl 1988 460 : 143 8.